Join us as we celebrate 50 years of BSAC! Infection 2021 is an exciting two-day hybrid conference looking at the challenges and future of infection management and how we can rise the meet the challenge of antimicrobial resistance. We encourage you to register for either in-person or virtual attendance and submit your abstracts for consideration […]

The 2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place online, Dec. 8-9, 2021.   Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) […]

This year’s WAAW will take place 18-24 November 2021, with the theme “Spread Awareness, Stop Resistance”. You can read more about WHO’s WAAW campaign here. The AMR Industry Alliance virtual panel session will be organized as short dialogues among experts from the public, private, academic and civil society sectors who will discuss key topics related to the optimal […]

Antimicrobials in the era of AMR During World Antimicrobial Awareness Week (Nov. 18-24 2021), the McGill AMR Centre and Innovation + Partnership office are hosting the inaugural McGill AMR Innovation Summit, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between McGill scientists and non-academic stakeholders. Program 14:00-14:30 Keynote speaker Erin Duffy, PhD (public event) […]

You’re invited to join this virtual event on Tuesday, 16 November, 2021 at 14:00 - 15:30 CET. The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of […]

The course provides state-of-the-art teaching in both human and veterinary vaccinology, drawing on the experience of the Jenner Institute at the University of Oxford, The Pirbright Institute, and this year's African host, the KEMRI Wellcome Trust Research Programme in Kenya.  These courses alternate between East and West Africa. In 2021, participation is limited to attendants […]

This is an international gathering dedicated to developing Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines, hosted by PATH, a global nonprofit dedicated to achieving health equity. Registration is now open for the VASE Virtual Symposium, which will be held online on 28 and 30 September 2021. Check out the full agenda and read the presentation abstracts. This fully virtual […]

As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective, the global community of public and private organizations and life science innovators are rallying around the Antimicrobial Resistance challenge. Johnson & Johnson Innovation has invited leading experts in the field to share their views. Why aren’t (enough) new […]

The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange information with the medical and scientific community about the […]

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was […]